Among these antiviral RNA helicases, we also reported that RNA helicase A (RHA) or DHX9 exits the nucleus in response to MYXV infection to form unique antiviral granules in the cytoplasm of infected human cancer cells. The gene discussed is DHX9; the disease is cancer.